William E. Steinkrauss

No más puestos en curso

Fortuna: 45 328 $ al 31/03/2024

39 años

Health Technology

Consumer Services

Perfil

William E.
Steinkrauss worked as a Director-Technical Accounting & Reporting at OvaScience, Inc. from 2015 to 2016.
Prior to that, he was a Senior Manager-Technical Accounting at Cubist Pharmaceuticals LLC from 2012 to 2015.
Currently, he is the Chief Financial & Administrative Officer at Curis, Inc. starting from 2016.
Steinkrauss completed his undergraduate and graduate degrees from Boston College.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
CURIS, INC. 0.07%	31/07/2023	4 170 ( 0.07% )	45 328 $	31/03/2024

Antiguos cargos conocidos de William E. Steinkrauss.

Empresas	Cargo	Fin
CURIS, INC.	Director of Finance/CFO	05/08/2022
OvaScience, Inc. OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA.	Corporate Officer/Principal	01/08/2016
CUBIST PHARMACEUTICALS INC	Corporate Officer/Principal	01/05/2015

Ver el detalle de la experiencia de William E. Steinkrauss.

Formación de William E. Steinkrauss.

Boston College

Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de William E. Steinkrauss.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
CURIS, INC.	Health Technology

Empresas privadas	2
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology
OvaScience, Inc. OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA.	Health Technology